Lilly Closes Dermira’s Menlo Park FacilityAcquisitions, Business, California, Eli Lilly, Excessive Armpit Sweating, Facilities, Immunology, Job Cuts, TherapeuticsEli Lilly is cutting 163 jobs by closing its Dermira facility in Menlo Park, Calif. and selling off the latter company’s sweat drug Qbrexza, which is being acquired by Journey Medical. Read more April 13, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/04/Lilly-Closes-Dermira’s-Menlo-Park-Facility-Cutting-163-Jobs-in-the-Process-BioSpace-4-13-21.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-04-13 12:11:482021-04-13 12:13:36Lilly Closes Dermira’s Menlo Park Facility